Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase.

Area of Science:

• Cardiovascular Physiology
• Molecular Biology
• Pharmacology

Background:

• Aging and hypertension are associated with arterial dysfunction.
• Soluble guanylyl cyclase (sGC) plays a critical role in vascular tone regulation via the nitric oxide (NO) pathway.
• Understanding sGC behavior in aging and hypertension is crucial for developing therapeutic strategies.

Purpose of the Study:

• To investigate the impact of aging and genetic hypertension on the expression and function of soluble guanylyl cyclase (sGC) in rat aortas.
• To determine how aging and hypertension affect the nitric oxide (NO)-stimulated guanylyl cyclase activity.
• To explore the relationship between sGC downregulation and arterial dysfunction.

Main Methods:

• Analysis of sGC (alpha(1) and beta(1) subunits) mRNA and protein expression in rat aortas.
• Assessment of sGC function using relaxant responses to the NO donor sodium nitroprusside in endothelium-denuded aortic rings.
• Comparison between young and old spontaneously hypertensive rats (SHR) and age-matched Wistar-Kyoto (WKY) rats.

Main Results:

• Vasodilator potency of sodium nitroprusside was significantly reduced with age and hypertension.
• Aging and hypertension led to a substantial decrease in beta(1) subunit protein expression.
• mRNA levels of alpha(1) and beta(1) subunits were lower in old SHR compared to old WKY rats.
• NO-stimulated guanylyl cyclase activity mirrored the changes in sGC expression.

Conclusions:

• Both aging and genetic hypertension significantly decrease sGC expression and its NO-dependent activation in aortic tissue.
• Downregulation of sGC is implicated in the arterial dysfunction observed in senescence and chronic hypertension.
• These findings highlight sGC as a potential therapeutic target for age-related and hypertension-induced vascular complications.